← Back to Search
Cyclodextrin-based SiRNA Delivery Nanocarriers: A State-of-the-art Review
K. Chaturvedi, K. Ganguly, A. R. Kulkarni, V. H. Kulkarni, Mallikarjuna N. Nadagouda, W. Rudzinski, T. M. Aminabhavi
Published 2011 · Materials Science, Medicine
Download PDFAnalyze on Scholarcy
Introduction: The discovery of synthetic small interfering RNA (siRNA) has led to a surge of interest in harnessing RNA interference (RNAi) technology for biomedical applications and drug development. Even though siRNA can be a powerful therapeutic drug, its delivery remains a major challenge, due to the difficulty in its cellular uptake. Naked siRNA has a biological half-life of less than an hour in human plasma. To increase the lifetime and improve its therapeutic efficacy, non-viral vectors have been developed. As a natural evolution, cyclodextrins (CDs), which are natural cyclic oligosaccharides, have recently been applied as delivery vehicles for siRNA, and this in turn, has led to a surge of interest in this area. Areas covered: This review discusses the recent advances made in the design of delivery strategies for siRNA, focusing on CD-based delivery vectors, because these have demonstrated clinical success. The methods of preparation of CD-based vectors, their characterization, transfection efficiencies, cellular toxicity, preclinical and clinical trials are also addressed, as well as future therapeutic applications. Expert opinion: siRNA-mediated RNAi therapeutics is beginning to transform healthcare, particularly, for the treatment of solid tumors. For example, CALAA01, a targeted, self-assembling nanoparticle system based on CD complexed with siRNA has been effective in phase I clinical trials. Although siRNA therapeutics suffers from problems related to off-target effects and non-specific gene silencing, these problems can be overcome by reducing the nanoparticle size, improving the targeting efficiency and by modifying the primary sequence of the siRNA.
This paper references
Progress towards in Vivo Use of siRNAs
M. Behlke (2006)
Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.
H. Hatakeyama (2011)
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
D. Rozema (2007)
Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery.
J. Li (2008)
Transfection ability and intracellular DNA pathway of nanostructured gene-delivery systems.
X. Zhang (2008)
Engineering RNA for Targeted siRNA Delivery and Medical Application☆
P. Guo (2010)
Biophysical and Structural Characterization of Polyethylenimine-Mediated siRNA Delivery in Vitro
Amy C Richards Grayson (2006)
Multiple and time-scheduled in situ DNA delivery mediated by beta-cyclodextrin embedded in a polyelectrolyte multilayer.
N. Jessel (2006)
Design and development of polymers for gene delivery
D. Pack (2005)
Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA
K. Woodrow (2009)
Folate-PEG-appended-PAMAM dendrimer (G3) conjugate with alpha-cyclodextrin as a tumor selective siRNA carrier
H Arima (2010)
Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells
S. Guo (2006)
Lipid-based Nanoparticles for Nucleic Acid Delivery
Weijun Li (2006)
Imidazole groups on a linear, cyclodextrin-containing polycation produce enhanced gene delivery via multiple processes.
Swaroop Mishra (2006)
Chitosan as a carrier for targeted delivery of small interfering RNA.
W. Rudzinski (2010)
Conquering RNAi Delivery Challenges. Genetic engineering and biotechnology
K. Liszewski (2008)
siRNA applications in nanomedicine.
Talar Tokatlian (2010)
Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.
J. Sunshine (2011)
Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.
S. Hu-Lieskovan (2005)
Development and characterisation of chitosan nanoparticles for siRNA delivery.
Haliza Katas (2006)
RNAi-mediated gene silencing in non-human primates
T. Zimmermann (2006)
Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells.
Motoi Oishi (2005)
Synthesis and complexation ability of a novel bis- (guanidinium)-tetrakis-(beta-cyclodextrin) dendrimeric tetrapod as a potential gene delivery (DNA and siRNA) system. Study of cellular siRNA transfection.
S. Menuel (2008)
Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity
A. Hollins (2007)
RNAi therapeutics: principles, prospects and challenges.
L. Aagaard (2007)
siRNA conjugate delivery systems.
J. Jeong (2009)
Progress Toward In Vivo Use of siRNAs-II
Garrett R Rettig (2012)
Cationic lipids and polymers mediated vectors for delivery of siRNA.
S. Zhang (2007)
In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.
D. Fischer (2003)
Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASP
O. Alekseev (2009)
Conquering RNAi Delivery Challenges. Genetic engineering and biotechnology News
Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.
J. Zhou (2008)
Nonviral delivery of synthetic siRNAs in vivo.
S. Akhtar (2007)
Enhancement of gene expression by polyamidoamine dendrimer conjugates with alpha-, beta-, and gamma-cyclodextrins.
Hidetoshi Arima (2001)
Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells.
Christina Lorenz (2004)
Cyclodextrin-containing polymer delivery system for light-directed siRNA gene silencing.
S. Bøe (2010)
Efficient down-regulation of CDK4 by novel lipid nanoparticle-mediated siRNA delivery.
X. Wang (2011)
GT Hermanson (1996)
Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
Toshihito Tsutsumi (2007)
Dendrimer poly (ethylenimine)s linked to beta-cyclodextrin
J Suh (1997)
Knocking down Disease with siRNAs
D. Dykxhoorn (2006)
Two novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-β-cyclodextrin or (2-hydroxypropyl)-γ-cyclodextrin
Hongliang Huang (2006)
Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity.
S. Moschos (2007)
Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice.
Naoyuki Murata (2008)
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
F. Xie (2006)
Delivery of RNA Interference
Charles X Li (2006)
Self-assembling nucleic acid delivery vehicles via linear, water-soluble, cyclodextrin-containing polymers.
M. Davis (2004)
RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo
B. Urban-Klein (2005)
Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung.
Mini P. Thomas (2005)
Nonviral methods for siRNA delivery.
K. Gao (2009)
Drug delivery of siRNA therapeutics: potentials and limits of nanosystems.
D. Reischl (2009)
Small RNAs Make Big Splash
J. Couzin (2002)
Development of a nonviral gene delivery vehicle for systemic application.
S. Pun (2002)
Phi29 pRNA vector for efficient escort of hammerhead ribozyme targeting survivin in multiple cancer cells
H. Li (2007)
Liposomes for phospholipase A2 triggered siRNA release: preparation and in vitro test.
C. Foged (2007)
G. T. Hermanson (1996)
Effects of Structure of β-Cyclodextrin-Containing Polymers on Gene Delivery
S. J. Hwang (2001)
Effects of structure of beta-cyclodextrin-containing polymers on gene delivery.
S. J. Hwang (2001)
Potential Use of Dendrimer/α-Cyclodextrin Conjugate as a Novel Carrier for Small Interfering RNA (siRNA)
Toshihito Tsutsumi (2006)
Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.
D. Bartlett (2007)
The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic.
M. Davis (2009)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J. Soutschek (2004)
Removal of spermatozoa with externalized phosphatidylserine from sperm preparation in human assisted medical procreation: effects on viability, motility and mitochondrial membrane potential
C. de Vantéry Arrighi (2009)
Recent advances of siRNA delivery by nanoparticles
Xu-dong Yuan (2011)
Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA
J. Heidel (2007)
A New Class of Polymers for the Delivery of Macromolecular Therapeutics
Sue Hwang (1999)
Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes.
T. Kim (2005)
Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.
Dana J Gary (2007)
Two novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-beta-cyclodextrin or (2-hydroxypropyl)-gamma-cyclodextrin.
Hongliang Huang (2006)
Gene therapy progress and prospects: synthetic polymer-based systems
D. Schaffert (2008)
Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging.
O. Merkel (2009)
Molecular medicine for the brain: silencing of disease genes with RNA interference
B. Davidson (2004)
Cationic cyclodextrin amphiphiles as gene delivery vectors
Sally-Ann Cryan (2004)
Dendrimer Poly(ethylenimine)s Linked to β-Cyclodextrin
J. Suh (1997)
Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNA.
Toshihito Tsutsumi (2008)
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging
D. Bartlett (2007)
Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
S. Akhtar (2007)
Side‐effects of a systemic injection of linear polyethylenimine–DNA complexes
P. Chollet (2002)
TARGETED DELIVERY OF siRNA TO CELL DEATH PROTEINS IN SEPSIS
P. Brahmamdam (2009)
Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins
Hidetoshi Arima (2001)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
M. Davis (2010)
Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
D. De Paula (2007)
In this review, the authors have compared different chitosan-based devices for siRNA delivery for cancer treatment
Improved Cell Viability of Linear Polyethylenimine through γ‐Cyclodextrin Inclusion for Effective Gene Delivery
A. Yamashita (2006)
Factors affecting drug and gene delivery: effects of interaction with blood components.
P. Opanasopit (2002)
Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions.
Kexiong Zhang (2008)
Interaction between an Adamantane End-Capped Poly(ethylene oxide) and a β-Cyclodextrin Polymer
A. Sandier (2000)
Delivery of siRNA Therapeutics: Barriers and Carriers
Jie Wang (2010)
This paper is referenced by
CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells
Rong Zhu (2015)
Human: Veterinary Technology Cross Over
A. Baird (2013)
Advanced Materials for Gene Delivery
M. Mazumder (2014)
Cationic polymers and their therapeutic potential.
S. K. Samal (2012)
Nano-enabled drug delivery systems for brain cancer and Alzheimer's disease: research patterns and opportunities.
J. Ma (2015)
Fabrication of polysulphone/hydroxyapatite nanofiber composite implant and evaluation of their in vitro bioactivity and biocompatibility towards the post-surgical therapy of gastric cancer
S. S. Saravanabhavan (2013)
Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA
Hidetoshi Arima (2011)
Production of chitosan-based hydrogels for biomedical applications
T. M. Aminabhavi (2017)
Modern approaches to the ocular delivery of cyclosporine A.
P. Agarwal (2016)
A simplified method for manufacturing RNAi therapeutics for local administration.
H. Ando (2019)
Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells.
Alan Hibbitts (2014)
Apoferritin applications in nanomedicine.
Z. Heger (2014)
Mechanism of Action and Gold Nanoparticle Delivery of Pt(IV) Prodrugs of Cisplatin
Y. Shi (2012)
Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system.
J. McCarthy (2013)
Small interfering RNA-loaded chitosan hydrochloride/carboxymethyl chitosan nanoparticles for ultrasound-triggered release to hamper colorectal cancer growth in vitro.
Ling Yan (2020)
The role of nanotechnology and chitosan-based biomaterials for tissue engineering and therapeutic delivery
T. M. Aminabhavi (2017)
Novel mannan-PEG-PE modified bioadhesive PLGA nanoparticles for targeted gene delivery
Guicun Wu (2012)
Self-assembling modified β-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on Huntington's disease.
B. Godinho (2013)
Guar gum as platform for the oral controlled release of therapeutics
T. M. Aminabhavi (2014)
Nanocarrier mediated siRNA delivery targeting stem cell differentiation.
Fiona Fernandes (2019)
Development of new self-assembling nanoparticles for the delivery of active agents for the treatment of tumors
G. Salzano (2014)
siRNA-BASED NANOPARTICLES: A NOVEL APPROACH FOR GENE SILENCING TO ENHANCE CANCER THERAPY
S. M. Shatil Shahriar (2019)
Electrochemical investigations for COVID-19 detection-A comparison with other viral detection methods
S. D. Bukkitgar (2020)
Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies
A. Santos (2020)
A review on cationic lipids with different linkers for gene delivery.
Defu Zhi (2018)
NUCLEIC ACID DELIVERY
Facile and green synthesis of palladium nanoparticles loaded into cyclodextrin nanofibers and their catalytic application in nitroarene hydrogenation
Asli Celebioglu (2019)
Recent developments in the co-delivery of siRNA and small molecule anticancer drugs for cancer treatment
M. Saraswathy (2014)
Polysaccharide-based Nanoparticles for Gene Delivery
Myung Sook Huh (2017)
Large Scale Production, Purification, and Modification of Chitosan-Based Complexes for Gene Therapy
Ashkan TavakoliNaeini (2017)
An update on applications of nanostructured drug delivery systems in cancer therapy: a review
Seyed Mohsen Aberoumandi (2017)
Inclusion complexes between amphiphilic phenyleneethynylene fluorophores and cyclodextrins in aqueous media.
Warathip Siripornnoppakhun (2012)See more